Phase II trial of dichloromethotrexate in patients with advanced squamous cell carcinoma of the cervix: a Gynecologic Oncology Group Study.
Roberts
J A
JA
Division of Gynecologic Oncology, University of Michigan Medical Center, Ann Arbor.
Blessing
J A
JA
McGehee
R
R
Beecham
J
J
Homesley
H D
HD
D000970:Antineoplastic Agents / Q000009:adverse effects / Q000627:therapeutic use; D002294:Carcinoma, Squamous Cell / Q000188:drug therapy*; D005260:Female; D005493:Folic Acid Antagonists / Q000009:adverse effects / Q000627:therapeutic use; D006801:Humans; D008727:Methotrexate / Q000009:adverse effects / Q000031:analogs & derivatives* / Q000627:therapeutic use; D002583:Uterine Cervical Neoplasms / Q000188:drug therapy*
D000970:Antineoplastic Agents; D005493:Folic Acid Antagonists; C004763:3',5'-dichloromethotrexate; D008727:Methotrexate